Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06543433
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-03
Brief Title:
Skincubator a Novel Incubator for Skin to Skin Contact Feasibility Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Skincubator Model 2 a Novel Incubator for Skin to Skin Contact Feasibility Study in Monash and Riverside
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to test the feasibility of using the Skincubator a wearable incubator for skin to skin contact of preterm babies and their parents It will also learn about the safety of skincubator The main questions it aims to answer are
Can the Skincubator keep a stable temperature for the smallest babies and the first days after birth
How many hours will the parents and other family members will succeed to perform skin to skin every day
Participants will
Be offered the opportunity to perform Skincubator care for as long as they want to each day during the week after enrolment
Can the Skincubator keep a stable temperature for the smallest babies and the first days after birth
How many hours will the parents and other family members will succeed to perform skin to skin every day
Participants will
Be offered the opportunity to perform Skincubator care for as long as they want to each day during the week after enrolment
Detailed Description:
Study design This is a non-randomized feasibility trial with no control group in which the investigators will offer parents the option to perform Skincubator care - being cared for in SSC inside the Skincubator which is placed on the mother andor another caregiver Skincubator care will be provided from birth if the caring team and the parents feel it is appropriate The option for Skincubator care will be provided for as long as the parents surrogates and staff feel comfortable with a goal of possible achievement of the WHO target of 8 hours per day Each infant will participate in the study for one week from enrollment If parents desire they will be able to continue using the Skincubator beyond 1 week as long as NICU staff feel that it is helpful for the baby
Implementation phase Prior to beginning the study each center will provide care in the Skincubator for five noninvasively ventilated preterm babies After gaining experience in treating a preterm baby in the Skincubator and performing manikin simulations of Skincubator care for invasively ventilated babies the NICU team in each center will be able to decide whether to include intubated babies in the trial
Population up to 25 preterm neonates in each site born at GA of 240-326 with birth weight of 15 kg
First 3 babies will be of GA of 26-326 and on noninvasive respiratory support Those babies will be considered a learning phase for the team and may be analyzed separately After completing the learning phase the study will proceed with 4 groups
1 Up to 7 more babies of GA of 26-326 and on noninvasive respiratory support
2 5 Intubated babies with GA of 26-326 The investigators will start enrolling babies from this group only after the team treated at least 5 babies from group 1 including the learning phase and feels ready to move on to intubated babies
3 5 babies GA 240-256 on noninvasive respiratory support The investigators will start enrolling babies from this group only after the team treated at least 5 babies from group 1 including the learning phase and feels ready to move on to this age group
4 5 intubated babies with GA of 240-256 The investigators will start enrolling babies from this group only after the team treated at least 3 babies from group 2 and 3 babies from group 3 and only if the team feels ready to move on to this group also
First five babies will be treated in the Skincubator only from NICU admission After gaining experience with the first 5 babies the team may decide to start Skincubator care in birth suite ideally on the mother potentially on the father if the mother prefers or is feeling unwell or in cesarean section theater on the father
Implementation phase Prior to beginning the study each center will provide care in the Skincubator for five noninvasively ventilated preterm babies After gaining experience in treating a preterm baby in the Skincubator and performing manikin simulations of Skincubator care for invasively ventilated babies the NICU team in each center will be able to decide whether to include intubated babies in the trial
Population up to 25 preterm neonates in each site born at GA of 240-326 with birth weight of 15 kg
First 3 babies will be of GA of 26-326 and on noninvasive respiratory support Those babies will be considered a learning phase for the team and may be analyzed separately After completing the learning phase the study will proceed with 4 groups
1 Up to 7 more babies of GA of 26-326 and on noninvasive respiratory support
2 5 Intubated babies with GA of 26-326 The investigators will start enrolling babies from this group only after the team treated at least 5 babies from group 1 including the learning phase and feels ready to move on to intubated babies
3 5 babies GA 240-256 on noninvasive respiratory support The investigators will start enrolling babies from this group only after the team treated at least 5 babies from group 1 including the learning phase and feels ready to move on to this age group
4 5 intubated babies with GA of 240-256 The investigators will start enrolling babies from this group only after the team treated at least 3 babies from group 2 and 3 babies from group 3 and only if the team feels ready to move on to this group also
First five babies will be treated in the Skincubator only from NICU admission After gaining experience with the first 5 babies the team may decide to start Skincubator care in birth suite ideally on the mother potentially on the father if the mother prefers or is feeling unwell or in cesarean section theater on the father
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None